Doherty Clinical Trials launches the #mRNA Platform Incubator Network

Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research

At the recent annual AusBiotech conference held in Brisbane, Australia, Moderna announced the highly anticipated launch of the #mRNA Platform Incubator Network.

Doherty Clinical Trials are proud to be partnering with Moderna on this pioneering initiative, which aims to advance mRNA medicine, foster scientific excellence in clinical translation in Australia and further the therapeutic potential of the mRNA platform.

The Platform Incubator Network brings together Australia’s leading minds in mRNA research including our team at Doherty Clinical Trials, Monash University and Monash Institute of Pharmaceutical Sciences (MIPS), the Peter Doherty Institute of Infection and Immunity – a joint venture of The University of Melbourne and The Royal Melbourne Hospital, Peter MacCallum Cancer Centre and the Murdoch Research Children’s Institute.

CEO, Dr Andrew Brockway has said “At Doherty Clinical Trials, we're excited to join the mRNA Platform Incubator Network with Moderna and other outstanding Australian institutions. This unique collaboration is a significant step forward in the realm of mRNA medicine research right here in Australia, and we're proud to contribute our expertise in infectious disease clinical trials to help accelerate the translation of mRNA research into practical, life-changing applications. This network of experts has the potential to drive real-world solutions that can improve healthcare outcomes and will be contributing to meaningful medical advancements globally, which is exactly why Doherty Clinical Trials was established.”

Based out of Moderna’s Regional Research Centre in Melbourne, the Platform Incubator Network will allow for regular cross-functional collaboration, exploration and execution of translational research projects, contribute new insights to the broader scientific and regulatory community through publications and discussions and support the development of the next generation of researchers.

November 16, 2023
News
Doherty Clinical Trials launches the #mRNA Platform Incubator Network

Doherty Clinical Trials launches the #mRNA Platform Incubator Network in collaboration with Moderna and other leading minds in bio-medical research

April 2, 2024
In the Media
In the News - CEO Dr Andrew Brockway interviewed by The Guardian

Delving further into the Doherty Clinical Trials experience and the purposes of human challenge trials, the article is another feature highlighting the company’s launch.

March 25, 2024
News
Australia's first purpose-built facility to deliver human challenge trials officially launches in Melbourne

Launched by Deputy Premier, The Honourable Ben Carroll MP and Professor Sharon Lewin AO, Director of the Doherty Institute in East Melbourne.

March 27, 2024
In the Media
In the News - Doherty Clinical Trials' CMO and CEO featured in The Age, with Professor Sharon Lewin.

Speaking about the importance of human challenge trials, the article coincides with the launch of Doherty Clinical Trials' facility in East Melbourne.

February 21, 2024
News
Bullwinkel Scholarship award for DCT's Nursing Director

Our Clinical Operations & Nursing Director receives prestigious Bullwinkel Scholarship award

March 8, 2024
News
The new home of Doherty Clinical Trials - coming soon

The new home of Doherty Clinical Trials at AIID set for 2027